A piecewise-homogeneous Markov chain process of lung transplantation

Journal of Epidemiology and Biostatistics

Volumn 6, Issue 4, 2001, Pages 349-355

  Sharples, L D ^a   Taylor, G J ^a   Faddy, M ^a  

^a MRC BIOSTATISTICS UNIT   (United Kingdom)

Author keywords

Event rates; Markov chain model

Indexed keywords

ACCURACY; ACUTE DISEASE; ARTICLE; BRONCHIOLITIS; CALCULATION; CHRONIC DISEASE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CYTOMEGALOVIRUS INFECTION; ECONOMIC ASPECT; EPIDEMIOLOGY; GRAFT REJECTION; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MAXIMUM LIKELIHOOD METHOD; OPPORTUNISTIC INFECTION; PROBABILITY; PUBLIC HEALTH; SURVIVAL;

ALGORITHMS; DISEASE PROGRESSION; HUMANS; LIKELIHOOD FUNCTIONS; LUNG TRANSPLANTATION; MARKOV CHAINS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 0035211627     PISSN: 13595229     EISSN: None     Source Type: Journal    
DOI: 10.1080/13595220152601828     Document Type: Article

References (22)

1. A Markov model for analyzing cancer markers and disease states in survival studies
2. Statistical analysis of the stages of HIV infection using a Markov model
3. Use of the Gibbs sampler to estimate transition rates between grades of coronary disease following cardiac transplantation
4. Multistate models in survival analysis: A study of nephropathy and mortality in diabetes
5. Multi-state models and diabetic retinopathy
6. Estimation of parasitic infection dynamics when detectability is imperfect
7. A Markov chain method to estimate the tumour progression rate from preclinical to clinical phase, sensitivity and positive predictive value for mammography in breast cancer screening
8. Estimating sensitivity and sojourn time in screening for colorectal cancer: A comparison of statistical approaches
9. Modelling age-specific risk: Application to dementia
10. Assessing the influence of reversible disease indicators on survival
11. A three-state Markov model of Plasmoodium falciparum parasitemia
12. The effects of covariates on the induction time of AIDS using improved imputation of exact seroconversion times
13. Markov chains with measurement error: Estimating the 'true' course of a marker of the progression of Human Immunodeficiency Virus disease
14. A mover-stayer mixture of Markov chain models for the assessment of dedifferentiation and tumour progression in breast cancer
15. A model of the health and economic impact of posttransfusion hepatitis C: Application to cost-effectiveness analysis of further expansion of HCV screening protocols
16. Cost-effectiveness of androgen suppression therapies in advanced prostate cancer
17. Health and economic benefits of increased beta-blocker use following myocardial infarction
18. Bronchiolitis obliterans syndrome: Incidence, natural history, prognosis and risk factors
19. A model for analyzing the cost of the main clinical events after lung transplantation
20. Predicting 10-year care requirements for older people with suspected Alzheimer's disease